22 January 2021 : Original article
Effect of Everolimus with Low-Dose Tacrolimus on Development of New-Onset Diabetes After Transplantation and Allograft Function in Kidney Transplantation: A Multicenter, Open-Label, Randomized Trial
Hyung Duk Kim1BEF, Ji-Yeun Chang1CDE, Byung Ha Chung1AB, Chan-Duck Kim2B, Sang-Ho Lee3B, Yeong Hoon Kim4B, Chul Woo Yang1ADG*DOI: 10.12659/AOT.927984
Ann Transplant 2021; 26:e927984
Figure 1 Overview of study protocol. The KT recipients who signed informed consents were allocated with randomization into 2 groups: “EVL group” or “TAC group,” at 6 months after KT. KT – kidney transplantation; Tac – tacrolimus; EVL – everolimus; D – day; M – month.